Skip to main content
Clinical Trials/NL-OMON29994
NL-OMON29994
Completed
Phase 3

European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 - a protocol for non metastatic rhabdomyosarcoma - EpSSG-RMS-2005

Academisch Medisch Centrum0 sites98 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Rhabdomyosarcoma
Sponsor
Academisch Medisch Centrum
Enrollment
98
Status
Completed
Last Updated
last year

Overview

Brief Summary

Trial is onging in other countries

Registry
who.int
Start Date
TBD
End Date
December 31, 2017
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with pathologically confirmed rhabdomyosarcoma
  • No evidence of metastatic disease
  • Age 6 months \- \< 21 years
  • Included in the High Risk Group

Exclusion Criteria

  • Previously treated except initial surgery
  • Pre\-existing illness preventing treatment
  • Previous malignant tumor

Outcomes

Primary Outcomes

Not specified

Similar Trials